OSCR logo

OSCAR HEALTH INC - CLASS A

OSCRNYSE
πŸ† #900 by market capEarnings Nov 5US Equity
$27.97β–² $0.30 (+1.08%)
πŸŒ™ After hours$27.92β–Ό 0.17%Regular close Β· extended-hours price shown
1hβ€”
24hβ–² 1.1%
7dβ–Ό 7.2%
14dβ–Ό 8.5%
30dβ–Ό 11.5%
1yβ–² 86.6%
🏦Market Cap
$7.25B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+27.5%
High Growth
πŸ“ŠGross Margin
44.9%
Healthy
πŸ’΅FCF Margin
28.3%
Strong
βš–οΈP/S Ratio
0.5x
Cheap
Otter Score
54
Weak

Trading Snapshot

Day Range
$27.54 – $28.26
52-Week Range
$10.69 – $33.10
Volume
$3.25B
Avg Volume
$3.53B
Shares Outstanding
259.3M
Next Earnings
Sep 20, 2026

Fundamentals Snapshot

Annual Revenue
$11.70B
Last Q Revenue
$4.88B
P/E Ratio
16.4
P/S Ratio
0.5x
EPS (TTM)
$1.82
Dividend Yield
0.00%

Why Investors Own OSCR

  • βœ“High-growth profile β€” revenue up -8.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 67% gross margin and 26% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$11.70Bβ–Ό βˆ’5.2% YoY
Gross Margin (TTM)
66.9%β–² +1.2% YoY
Operating Income (TTM)
$2.91Bβ–Ό βˆ’5.2% YoY
Free Cash Flow (TTM)
$3.04Bβ–Ό βˆ’5.2% YoY

About OSCAR HEALTH INC - CLASS A

Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
54/100

Analyst Price Target

β“˜
Average Target
$29.70
β–² +6.2% Upside
High Target$34.57
Low Target$22.63
Based on 41 analysts

Latest News & Updates